Cargando…
The role transition of radiotherapy for the treatment of liver cancer in the COVID-19 era
The uncontrollable COVID-19 crises in the SARS-CoV-2 high-prevalence areas have greatly disrupted the routine treatment of liver cancer and triggered a role transformation of radiotherapy for liver cancer. The weight of radiotherapy in the treatment algorithm for liver cancer has been enlarged by th...
Autores principales: | Li, Zheng, Hu, Yue, Zeng, Ming, Hu, Qinyong, Ye, Fei, Liu, Ruifeng, Cai, Hongyi, Li, Qiang, Wang, Xiaohu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516283/ https://www.ncbi.nlm.nih.gov/pubmed/36185295 http://dx.doi.org/10.3389/fonc.2022.976143 |
Ejemplares similares
-
Prognostic Value of Inflammatory Markers in Nasopharyngeal Carcinoma Patients in the Intensity-Modulated Radiotherapy Era
por: Li, Qian, et al.
Publicado: (2021) -
Review of possible mechanisms of radiotherapy resistance in cervical cancer
por: Zhang, Hanqun, et al.
Publicado: (2023) -
Postoperative Radiotherapy for Patients With Resectable Stage III-N2 Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
por: Lei, Tianyu, et al.
Publicado: (2021) -
Prognostic Factors of Survival of Advanced Liver Cancer Patients Treated With Palliative Radiotherapy: A Retrospective Study
por: Hua, Qingling, et al.
Publicado: (2021) -
Recent progress of hydrogel-based local drug delivery systems for postoperative radiotherapy
por: Xie, Yandong, et al.
Publicado: (2023)